Antje Prasse MD

Prof. Antje Prasse is a respiratory specialist and renowned expert in the field of interstitial lung diseases (ILD), who received her training at the Albert Ludwig University of Freiburg, Germany. She has dedicated her career to clinical and translational pulmonary research and was head of the ILD center at the University Medical Center Freiburg for seven years. She made major contributions to translational research in the ILD field, e.g. a publication on the first serum biomarker predictive of mortality in idiopathic pulmonary fibrosis (IPF). Owing to her track record in personalized medicine and biomarkers she was appointed to a visiting professorship at Yale University (host Prof. Naftali Kaminski) for the period 2013/2014.

In 2014, she transferred to the Hannover Medical School and Fraunhofer ITEM in Hannover, Germany. At the Hannover Medical School, she established a clinical ILD center which, within 15 months only, rapidly developed into one of Germany’s largest tertiary ILD centers, now following more than 500 ILD patients including more than 100 IPF patients. Multiple clinical trials are currently ongoing. In parallel with her work at the Hannover Medical School, Prof. Prasse is head of a research group at Fraunhofer ITEM that is being funded by the Fraunhofer Attract program. Over the past years, her group has gained expertise in several omics techniques and has established in-vitro models as well as a humanized mouse model of IPF. In 2015, Prof. Prasse received the Research Award on Idiopathic Pulmonary Fibrosis from the European Respiratory Society.